Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript

29 September 2026

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 29
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » West Bancorporation, Inc. (WTBA) Q2 2026 Earnings Call Transcript
News

West Bancorporation, Inc. (WTBA) Q2 2026 Earnings Call Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk23 July 20261 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
West Bancorporation, Inc. (WTBA) Q2 2026 Earnings Call Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

Operator

Ladies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to West Bancorporation Second Quarter 2026 Earnings Conference Call. [Operator Instructions]

I would now like to turn the conference over to Jane Funk, CFO. Please go ahead.

Jane Funk
Executive VP, Treasurer & CFO

Thank you. Good afternoon, everyone. I’m Jane Funk, the CFO of West Bancorporation, Inc., and I’d like to welcome the participants on our call today, and thank you for joining us. With me today are Dave Nelson, our CEO; Harlee Olafson, Chief Risk Officer; Todd Mather, our Central Iowa Market President; and Brad Peters, our Minnesota Group President. During today’s conference call, we may make projections or other forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding future events or the future financial performance of the company.

We caution that such statements are predictions and that actual results may differ materially. Please see the forward-looking statement disclosure in our 2026 second quarter earnings release for more information about risks and uncertainties, which may affect us. The information we will provide today is accurate as of June 30, 2026, and we undertake no duty to update the information.

With that, I’ll turn it over to Dave Nelson.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Precision Optics Corporation, Inc. (POCI) Q4 2026 Earnings Call Transcript

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

Zymeworks Inc. (ZYME) M&A Call Transcript

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

BitGo: Down 55% From The IPO, With A Bank Charter And No Debt (NYSE:BTGO)

Kinross Gold: The Pullback I Waited For Came With Damage Attached (NYSE:KGC)

Editors Picks

Royal Gold, Inc. (RGLD) Presents at Mining Forum Americas 2026 Transcript

28 September 2026

Zymeworks Inc. (ZYME) M&A Call Transcript

28 September 2026

Meta: More Cautious Than Before, More Bullish Than Ever (NASDAQ:META)

28 September 2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Transcript

28 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Bitcoin: The Beginning Of The Next Bull Market (Cryptocurrency:BTC-USD)

28 September 2026

'Chancellor John Healey's Budget will reveal winners and losers as hope meets reality next month'

28 September 2026

Crown Castle: Buy This High Yield While It’s Undervalued (NYSE:CCI)

28 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.